Using Signos mHealth Platform in Adults for Weight Management (NCT06214221)
A Randomized Controlled Trial Evaluating the Safety and Effectiveness of the Intelligently-Driven Signos System for Personalized Weight Management in Overweight and Obese Adults
🩺 Plain-English Summary (8th-Grade Level)
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. The investigators hypothesize that the use of CGM data and targeted coaching and nutrition education will assist with weight optimization goals in the general (non-diabetic) population using the Signos mHealth platform, with associated health benefits.
Who can join: Review the eligibility criteria below.
Location: Helios Clinical Research (Phoenix) — Phoenix, Arizona
Age range: 22 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- Helios Clinical Research (Phoenix) — Phoenix, Arizona
- Diablo Clinical Research — Walnut Creek, California
- Segal Trials — North Miami, Florida
- Helios Clinical Research — Houston, Texas
- Seattle Clinical Research — Seattle, Washington
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight and Obesity
- Becoming United in Lifestyle Decisions — Hartford, Connecticut
- Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia — Columbia, Missouri
- Solutions for Hunger And Regulating Eating — La Jolla, California
- Timing Intervention of Morning Versus Evening Exercise — Aurora, Colorado
- Stepping Into Lifestyle Changes — Birmingham, Alabama
- An Open Label 100 Person Study Evaluating a Natural Supplement for Weight Loss and Fat Loss. — West Palm Beach, Florida
Explore by condition: All Overweight and Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.